The collaboration pairs Mimulus's molecular architecture with GenScript's massive synthesis scale to liberate critical grid power for AI compute and launch the "Forever Archive" for enterprise data ...

In the world of advanced medical research, the convergence of synthetic biology and cellular immunotherapy has inaugurated a new era in field of cancer treatment. Simultaneously, life science research ...

The multi-year collaboration aims to scale molecular data storage infrastructure and unlock breakthrough cost efficiencies by ...

PISCATAWAY, N.J., Jan. 14, 2025 /PRNewswire/ -- GenScript Biotech Corporation has unveiled an innovation in shipping packaging, propelling GenScript towards achieving their ambitious sustainability ...

PISCATAWAY, N.J., Aug. 8, 2025 /PRNewswire/ -- GenScript Biotech Corporation (HK.1548), a global leader in life sciences innovation, today unveiled its new global brand platform: Scripting ...

GenScript USA Inc. opened an automated gene synthesis and plasmid preparation facility in Piscataway near its U.S. headquarters on Nov. 2. The opening of the more than 50,000-square-foot facility ...

GenScript ProBio is the subsidiary of GenScript Biotech Corp. (HK.1548), building upon GenScript’s solid gene synthesis technology and deep expertise in the antibody, cell, and gene therapy fields, ...

In the rapidly evolving world of cancer treatments, CAR-T cell therapy stands out for its effectiveness tackling hematologic tumors. Booming demand for such therapies powered Legend Biotech Corp. LEGN ...

(Reuters) -The U.S. House of Representatives committee on China on Tuesday sent a letter to the directors of the FBI and national intelligence, renewing its concerns about GenScript Biotechnology's ...

GenScript is delighted to announce its 3rd Annual Virtual Summit on Gene and Cell Engineering. This gathering will feature leaders in the life sciences from academia, pharma, and biotech, leveraging ...

Although these are uncertain times, one thing I am certain of is that with synthetic biology and life sciences companies stepping in to help from all around the world, scientists like Liusong Yin may ...

GenScript’s cell therapy revenue grew by 143.7% last year as a CAR-T cell therapy developed by its Legend Biotech subsidiary gained traction. Legend Biotech continues to invest in R&D to expand the ...